DANA Compared to MACE in Evaluation of Suspected Acute Concussion
Primary Purpose
Brain Concussion, Traumatic Brain Injury
Status
Completed
Phase
Not Applicable
Locations
Afghanistan
Study Type
Interventional
Intervention
DANA Rapid
MACE
Sponsored by
About this trial
This is an interventional screening trial for Brain Concussion focused on measuring Concussion, Mild traumatic brain injury, DANA, MACE
Eligibility Criteria
Inclusion Criteria:
- Active duty military personnel
- Glasgow Coma Scale (GCS)score of 15, as assessed by the study member at the time of clinical evaluation following involvement in a mandatory event.
- Willingness to participate in the study, ability to communicate and comply with the study protocol and ability to provide informed consent
Exclusion Criteria:
- GCS score of less than 15
Sites / Locations
- Concussion Restoration Care Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Concussed
Non-concussed
Arm Description
Subjects who are diagnosed with a concussion by a clinician will be assessed with the MACE and DANA Rapid every 24 hours for up to 72 hours post-injury.
Subjects will have been exposed to a potentially concussive event but be clinically evaluated and found not to have sustained a concussion. Control subjects from this arm will take both the MACE and DANA Rapid twice: once within 24 hours of potentially concussive event, and again on the day of return to duty.
Outcomes
Primary Outcome Measures
Sensitivity
The primary hypothesis is that an abnormal score on the DANA Rapid will positively identify a greater proportion of concussed individuals than an abnormal cognitive score on the MACE would. Conversely, scores within normal range on the DANA Rapid should be able to rule out cognitive deficits more accurately than a normal score on the MACE
Secondary Outcome Measures
Serial Performance
The secondary hypothesis of the study is that scores on the DANA Rapid exam will improve over time as the subject recovers from concussion.
Full Information
NCT ID
NCT01728129
First Posted
November 8, 2012
Last Updated
October 5, 2017
Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators
U.S. Army Medical Research and Development Command
1. Study Identification
Unique Protocol Identification Number
NCT01728129
Brief Title
DANA Compared to MACE in Evaluation of Suspected Acute Concussion
Official Title
Comparison of the Defense Automated Neurobehavioral Assessment (DANA) Tool to the Military Acute Concussion Evaluation (MACE) in the Evaluation of Suspected Acute Concussion
Study Type
Interventional
2. Study Status
Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
November 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Collaborators
U.S. Army Medical Research and Development Command
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to compare the sensitivity of the DANA Rapid exam with the MACE cognitive score. The primary hypothesis is that the DANA Rapid exam will be more sensitive for detecting impaired cognitive performance than the MACE cognitive score in the setting of a clinical diagnosis of concussion at the point of injury in the combat setting. A secondary purpose of this study is to examine a serial performance on the DANA Rapid exam in those subjects diagnosed with a concussion. The secondary hypothesis is that the DANA Rapid exam will show improvements in performance during the recovery period after concussion.
Detailed Description
In Operations Iraqi Freedom and Enduring Freedom (OIF/OEF), over 60% of combat casualties have been the result of explosive blasts, and many of these critical injuries involve trauma to the head. As a result, traumatic brain injury (TBI) has been deemed a "signature wound" of OIF and OEF. The symptoms of head injuries, particularly of concussion/mild TBI (mTBI), can be sever but subtle, suggesting that early and accurate diagnosis is paramount to a wounded warrior's appropriate medical care. Most first providers in the war theater are medics who could benefit from an improved diagnostic test to better identify service members with concussion/mTBI. The MACE cognitive test is heavily weighted towards memory, is not 100% specific, and does not preclude a diagnosis of concussion being rendered despite a score in the normal range. Thus, an objective test of neurocognitive function, such as the DANA Rapid, that can be rapidly administered in theater by a combat medic would be highly beneficial to accurate clinical diagnosis and timely treatment. The results of the present study will provide information on the predictive value of the newly developed DANA handheld computer in assisting in the diagnosis of concussion in service members who have been blast exposed. If the DANA Rapid exam proves to be equally or more accurate than the MACE in detecting cognitive deficits, these tests and the handheld computer will also contribute to improved health care for service members by minimizing the time between injury and diagnosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Concussion, Traumatic Brain Injury
Keywords
Concussion, Mild traumatic brain injury, DANA, MACE
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Concussed
Arm Type
Experimental
Arm Description
Subjects who are diagnosed with a concussion by a clinician will be assessed with the MACE and DANA Rapid every 24 hours for up to 72 hours post-injury.
Arm Title
Non-concussed
Arm Type
Active Comparator
Arm Description
Subjects will have been exposed to a potentially concussive event but be clinically evaluated and found not to have sustained a concussion. Control subjects from this arm will take both the MACE and DANA Rapid twice: once within 24 hours of potentially concussive event, and again on the day of return to duty.
Intervention Type
Device
Intervention Name(s)
DANA Rapid
Intervention Description
The DANA Rapid is a neurocognitive test self-administered on a small handheld computer. The DANA Rapid subtests measure simple reaction time, procedural reaction time, and reaction time sensitivity.
Intervention Type
Other
Intervention Name(s)
MACE
Intervention Description
The MACE is currently the only standardized and Department of Defense-designated method for the initial evaluation of suspected concussion in military operational settings. The MACE documents the history of the injury-causing incident; assesses cognitive deficits in orientation, immediate memory, concentration, and delayed recalls; and involves a neurological screening by a clinician.
Primary Outcome Measure Information:
Title
Sensitivity
Description
The primary hypothesis is that an abnormal score on the DANA Rapid will positively identify a greater proportion of concussed individuals than an abnormal cognitive score on the MACE would. Conversely, scores within normal range on the DANA Rapid should be able to rule out cognitive deficits more accurately than a normal score on the MACE
Time Frame
72 hours from initial injury
Secondary Outcome Measure Information:
Title
Serial Performance
Description
The secondary hypothesis of the study is that scores on the DANA Rapid exam will improve over time as the subject recovers from concussion.
Time Frame
72 hours from initial injury
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Active duty military personnel
Glasgow Coma Scale (GCS)score of 15, as assessed by the study member at the time of clinical evaluation following involvement in a mandatory event.
Willingness to participate in the study, ability to communicate and comply with the study protocol and ability to provide informed consent
Exclusion Criteria:
GCS score of less than 15
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jack W. Tsao, MD, DPhil
Organizational Affiliation
U.S. Navy Bureau of Medicine and Surgery (BUMED)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Concussion Restoration Care Center
City
Camp Leatherneck
Country
Afghanistan
12. IPD Sharing Statement
Learn more about this trial
DANA Compared to MACE in Evaluation of Suspected Acute Concussion
We'll reach out to this number within 24 hrs